These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex. Schulze-Gahmen U, Echeverria I, Stjepanovic G, Bai Y, Lu H, Schneidman-Duhovny D, Doudna JA, Zhou Q, Sali A, Hurley JH. Elife; 2016 Oct 12; 5():. PubMed ID: 27731797 [Abstract] [Full Text] [Related]
4. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2. García-Martínez LF, Mavankal G, Peters P, Wu-Baer F, Gaynor RB. J Mol Biol; 1995 Dec 01; 254(3):350-63. PubMed ID: 7490754 [Abstract] [Full Text] [Related]
5. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR. Proc Natl Acad Sci U S A; 1999 Jul 06; 96(14):7791-6. PubMed ID: 10393900 [Abstract] [Full Text] [Related]
7. AFF4 binding to Tat-P-TEFb indirectly stimulates TAR recognition of super elongation complexes at the HIV promoter. Schulze-Gahmen U, Lu H, Zhou Q, Alber T. Elife; 2014 Apr 24; 3():e02375. PubMed ID: 24843025 [Abstract] [Full Text] [Related]
8. Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4. Gu J, Babayeva ND, Suwa Y, Baranovskiy AG, Price DH, Tahirov TH. Cell Cycle; 2014 Apr 24; 13(11):1788-97. PubMed ID: 24727379 [Abstract] [Full Text] [Related]
9. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery. Chavali SS, Bonn-Breach R, Wedekind JE. J Biol Chem; 2019 Jun 14; 294(24):9326-9341. PubMed ID: 31080171 [Abstract] [Full Text] [Related]
10. Tackling Tat. Karn J. J Mol Biol; 1999 Oct 22; 293(2):235-54. PubMed ID: 10550206 [Abstract] [Full Text] [Related]
11. HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1. Zhang J, Tamilarasu N, Hwang S, Garber ME, Huq I, Jones KA, Rana TM. J Biol Chem; 2000 Nov 03; 275(44):34314-9. PubMed ID: 10944537 [Abstract] [Full Text] [Related]
12. An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb. Shortridge MD, Wille PT, Jones AN, Davidson A, Bogdanovic J, Arts E, Karn J, Robinson JA, Varani G. Nucleic Acids Res; 2019 Feb 20; 47(3):1523-1531. PubMed ID: 30481318 [Abstract] [Full Text] [Related]
13. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Garber ME, Wei P, KewalRamani VN, Mayall TP, Herrmann CH, Rice AP, Littman DR, Jones KA. Genes Dev; 1998 Nov 15; 12(22):3512-27. PubMed ID: 9832504 [Abstract] [Full Text] [Related]
16. Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction. Hamasaki T, Okamoto M, Baba M. Antimicrob Agents Chemother; 2013 Mar 15; 57(3):1323-31. PubMed ID: 23274668 [Abstract] [Full Text] [Related]
18. Evidence for conformational flexibility in the Tat-TAR recognition motif of cyclin T1. Das C, Edgcomb SP, Peteranderl R, Chen L, Frankel AD. Virology; 2004 Jan 05; 318(1):306-17. PubMed ID: 14972556 [Abstract] [Full Text] [Related]
19. The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat. Schulze-Gahmen U, Upton H, Birnberg A, Bao K, Chou S, Krogan NJ, Zhou Q, Alber T. Elife; 2013 Mar 05; 2():e00327. PubMed ID: 23471103 [Abstract] [Full Text] [Related]